Trial Profile
Phase II study of weekly topotecan in patients treated for metastatic colorectal cancer
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 18 Jul 2023
Price :
$35
*
At a glance
- Drugs Topotecan (Primary)
- Indications Colorectal cancer
- Focus Therapeutic Use
- 02 May 2011 Actual end date (Apr 2006) added as reported by ClinicalTrials.gov.
- 02 May 2011 Status changed from active, no longer recruiting to completed reported by ClinicalTrials.gov.
- 05 Nov 2005 New trial record.